177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Leptomeningeal Metastasis|Solid Tumor, Adult
Interventions: BIOLOGICAL: radiolabeled DPTA-omburtamab
Sponsor: Y-mAbs Therapeutics